Literature DB >> 358762

Salmon calcitonin in the acute treatment of moderate and severe hypercalcemia in man.

O Nilsson, S Almqvist, B E Karlberg.   

Abstract

The effect of i.v. infusions with salmon calcitonin was evaluated in the treatment of acute hypercalcemia in 12 patients. Clinical improvement and a less critical level of serum calcium were achieved within 24 hours for eight of the patients, for another two after treatment for 48 hours. In malignant conditions (six patients) calcitonin was less effective, which could be evaluated within 24 hours. In addition to rehydration, the rapid onset of action and the lack of side-effects make calcitonin a drug of first choice in the treatment of acute hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 358762     DOI: 10.1111/j.0954-6820.1978.tb08434.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  3 in total

1.  Nasal human calcitonin for tumor-induced hypercalcemia.

Authors:  J C Dumon; A Magritte; J J Body
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

2.  Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Authors:  D J Hosking; S R Heller
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 3.  Pharmacology and therapeutic use of calcitonin.

Authors:  J C Stevenson; I M Evans
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.